Bedel Financial Consulting, Inc. Novavax Inc Transaction History

Bedel Financial Consulting, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$36.28 - $75.29 $4,389 - $9,110	-121 Closed	0 $0
Q4 2021 Jan 11, 2022	BUY	$134.56 - $217.97 $672 - $1,089	5 Added 4.31%	121 $17,000
Q2 2021 Aug 03, 2021	SELL	$121.0 - $257.67 $30,250 - $64,417	-250 Reduced 68.31%	116 $25,000
Q4 2020 Feb 02, 2021	BUY	$78.74 - $139.5 $9,133 - $16,182	116 Added 46.4%	366 $41,000
Q3 2020 Oct 20, 2020	BUY	$79.44 - $178.51 $19,860 - $44,627	250 New	250 $27,000

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Bedel Financial Consulting, Inc., based on Form 13F filings with the SEC.

Stay updated on Bedel Financial Consulting, Inc. with notifications on news.